Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions
- 15 April 1999
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 18 (15), 2451-2459
- https://doi.org/10.1038/sj.onc.1202565
Abstract
Inheritance of germ-line mutant alleles of BRCA1 and BRCA2 confers a markedly increased risk of breast cancer and we have previously reported a higher incidence of p53 mutations in these tumours than in grade matched sporadic tumours. We have now characterized these p53 mutants. The results of these studies identify a novel class of p53 mutants previously undescribed in human cancer yet with multiple occurrences in BRCA-associated tumours which retain a profile of p53-dependent activities in terms of transactivation, growth suppression and apoptosis induction which is close or equal to wild-type. However, these mutants fail to suppress transformation and exhibit gain of function transforming activity in rat embryo fibroblasts. These mutants therefore fall into a novel category of p53 mutants which dissociate transformation suppression from other wild-type functions. The rarity of these mutants in human cancer and their multiple occurrence in BRCA-associated breast tumours suggests that these novel p53 mutants are selected during malignant progression in the unique genetic background of BRCA1- and BRCA2-associated tumours.Keywords
This publication has 33 references indexed in Scilit:
- Partial rescue of Brca15–6 early embryonic lethality by p53 or p21 null mutationNature Genetics, 1997
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the MouseCell, 1996
- p53: puzzle and paradigm.Genes & Development, 1996
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- Induction of apoptosis in HeLa cells by trans-activation-deficient p53.Genes & Development, 1995
- Tumor suppressor p53 is a direct transcriptional activator of the human bax geneCell, 1995
- Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.Genes & Development, 1994
- p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genesNature, 1994